MANF and renal cell carcinoma: To address ER stress resistance mechanisms in RCC, ALKBH5 small-molecule inhibitors have been demonstrated to effectively reduce MANF expression in preclinical models, thereby enhancing tumor cell susceptibility to ER stress-induced apoptosis.